Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Passage BIO, Inc. (PASG)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q |
| Revenues | 100.0% | 100.0% | 100.0% | | | | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 0.0% | 0.0% | | | | 271.7% | 215.1% |
| Gross profit | 100.0% | 100.0% | 100.0% | | | | -171.7% | -115.1% |
| Research and development | 4259.9% | 24341.6% | -3153.3% | | | | 404.7% | 298.6% |
| General and administrative | 3066.7% | 16917.1% | -1808.0% | | | | 253.1% | 173.3% |
| Depreciation | 242.9% | 1198.1% | -134.8% | | | | 4.2% | 2.6% |
| EBIT | -7421.8% | -41734.9% | 5071.2% | | | | -829.5% | -587.0% |
| Pre-tax income | -7099.9% | -40524.4% | 4988.1% | | | | -827.3% | -585.6% |
| Income taxes | 0.0% | 0.0% | 0.0% | | | | 0.0% | 0.0% |
| Net income | -7099.9% | -40524.4% | 4988.1% | | | | -827.3% | -585.6% |
|